Header Logo

Connection

STACEY BERG to Antineoplastic Agents, Immunological

Back to Details
This is a "connection" page, showing publications STACEY BERG has written about Antineoplastic Agents, Immunological.
STACEY BERG
Connection Strength
0.145
Antineoplastic Agents, Immunological
  1. Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial. Lancet Oncol. 2020 04; 21(4):541-550.
    View in: PubMed
    Score: 0.145
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.